Entera Bio Ltd. (ENTX)
2024-12-31 | ||||
---|---|---|---|---|
Revenues | 181 | |||
Cost of revenue | 172 | |||
Gross profit | 9 | |||
Research and development expense | 4,499 | |||
General and administrative expense | 5,095 | |||
Operating expenses | 9,594 | |||
Operating income (loss) | -9,585 | |||
Nonoperating income (expense) | 58 | |||
Income (loss) from continuing operations before income taxes, noncontrolling interest | -9,527 | |||
Income tax expense (benefit) | 14 | |||
Net loss | -9,541 | |||
Basic eps | 0.25 | |||
Diluted eps | 0.25 | |||
Basic average shares | 37,650,179 | |||
Diluted average shares | 37,650,179 |